Tessella Biosciences
PrivateLast Round
Accelerator
Mar 12, 2026
Total Funding Raised
$600,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tessella Biosciences operates in Healthcare & Life Sciences and is based in Hamilton, Ontario. Its latest recorded funding round was an Accelerator round in March 2026.
Tessella Biosciences is a biotechnology company that develops and commercializes ready-to-use bioinks for 3D bioprinting, tissue engineering, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tessella Biosciences Comparables
Compare Tessella Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axolotl Biosciences | 87% | |
| BIO INX | 86% | |
| Foldink | 85% |
For institutional investors. Book with your work email.
Tessella Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 12, 2026 | ||||
| Seed | Oct 10, 2025 | ||||
| Pre Seed | Oct 9, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tessella Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioCreate Program | Accelerator |
| Federal Economic Development Agency for Southern Ontario | Accelerator |
| McMaster University | Pre Seed, Seed |
| Ontario Genomics | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
$150K grant from BioCreate Program, Federal Economic Development Agency, and Ontario Genomics.
- Oct 10, 2025
$176K round led by McMaster Seed Fund
For institutional investors. Book with your work email.
Tessella Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tessella Biosciences's valuation, stock price, and market status.
Is Tessella Biosciences a public or private company?
Tessella Biosciences is a private company.
What is the current stock price of Tessella Biosciences?
Tessella Biosciences is a private company, so its shares have no public market price. Caplight tracks Tessella Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tessella Biosciences worth (valuation)?
Valuation information for Tessella Biosciences is not publicly available.
Can I buy Tessella Biosciences stock?
Tessella Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tessella Biosciences's last funding round?
Tessella Biosciences's most recent funding round was Accelerator on March 12, 2026.
Who are the main investors in Tessella Biosciences?
Key investors in Tessella Biosciences include McMaster University.
Will Tessella Biosciences IPO soon?
No public IPO plans have been announced for Tessella Biosciences.
How can I track Tessella Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Tessella Biosciences's shares on secondary markets.